Drug
Hetrombopag clinical trials
Also written SHR8735.
Includes 24 studies of Hetrombopag olamine.
- studies test it
- 52
- open now
- 23
- in phase 3
- 12
- first study started
- 2012
Keep track of what changes. Save the hetrombopag studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Combined with it in one product
Studies by the year they started
52 studies that test it; most in 2022 (10)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 10 |
| 2023 | 8 |
| 2024 | 5 |
| 2025 | 7 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 14
- Phase 2
- 24
- Phase 3
- 12
- Phase 4
- 2
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 23 · Other 29
Jiangsu HengRui Medicine Co., Ltd. (22) · Institute of Hematology & Blood Diseases Hospital, China (4) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (4) · Peking Union Medical College Hospital (3) · Henan Cancer Hospital (2) · Sun Yat-sen University (2) · Fujian Cancer Hospital (2) · Atridia Pty Ltd. (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses hetrombopag is read from its arms, and is right about nine times in ten.
Testing it · 52
- A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia (ExCIT)RecruitingPhase 3Jiangsu HengRui Medicine Co., Ltd.NCT07286032Written as Hetrombopag Olamine
- Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal TumorsRecruitingPhase 2Changhai HospitalNCT07492693Written as Hetrombopag
- A Clinical Study on the Efficacy and Safety of Hetrombopag in the Treatment of Thrombocytopenia Induced by Gynecological Tumor TherapyNot yet recruitingPhase 2Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNCT07408648Written as hetrombopag 7.5 mg orally once daily
- A Study of Hetrombopag Combined With rhTPO in the Treatment of Cancer Therapy-induced Thrombocytopenia (CTIT) in Solid Tumor Patients.Not yet recruitingPhase 2Sun Yat-sen UniversityNCT07334093Written as rhTPO + hetrombopag
- Hetrombopag in Promoting Platelet Engraftment After Auto-HSCT in Children With NeuroblastomaRecruitingNot applicableBeijing Children's HospitalNCT06818916Written as Hetrombopag
- Herombopag Treated T-DM1 Induced Platelet ReductionRecruitingPhase 2Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNCT07257809Written as Herombopag Olamine Tablets
- A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal CarcinomaNot yet recruitingPhase 2Fujian Cancer HospitalNCT07252375Written as herombopag olamine tablets
- Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 StudyNot yet recruitingPhase 2Fujian Cancer HospitalNCT07243418Written as herombopag olamine tablets
- Primary Prevention of Thrombocytopenia Associated With T-DM1 Therapy in HER2 Positive Breast Cancer With HerombopagNot yet recruitingNot applicableZhenzhen LiuNCT07198672Written as Herombopag
- A Prospective, Multicenter Clinical Study of Hetrombopag in the Prevention of Thrombocytopenia Caused by Lung Cancer TherapyNot yet recruitingPhase 2Shanghai Pulmonary Hospital, Shanghai, ChinaNCT07101627Written as Hetrombopag Tablets
- A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primary ITPRecruitingPhase 2Institute of Hematology & Blood Diseases Hospital, ChinaNCT06838949Written as herombopag olamine tablets
- Herombopag for Chemotherapy-induced ThrombocytopeniaRecruitingPhase 2Institute of Hematology & Blood Diseases Hospital, ChinaNCT05236582Written as Herombopag
- Herombopag for the Prevention of Radio-chemotherapy Induced Thrombocytopenia in Cervical CancerNot yet recruitingPhase 2Peking University Cancer Hospital & InstituteNCT06745219Written as herombopag
- Clinical Study on Efficacy and Safety of Hetrombopag in the Preoperative Patients of ThrombocytopeniaRecruitingPhase 4The Third People's Hospital of ChengduNCT06562738Written as Hetrombopag
- TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment TerminationRecruitingPhase 2Peking Union Medical College HospitalNCT06478537Written as Hetrombopag Olamine
- Hetrombopag for the Thrombocytopenia Induced by Concurrent ChemoradiotherapyRecruitingPhase 2Sir Run Run Shaw HospitalNCT06433830Written as Hetrombopag Olamine
- Study of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects.Not yet recruitingPhase 1Jiangsu HengRui Medicine Co., Ltd.NCT06346925Written as Herombopag Olamine Tablets
- Efficacy and Safety of Herombopag in Patients With Thrombocytopenia Before HepatectomyRecruitingPhase 2Fudan UniversityNCT05442632Written as Hetrombopag
- The Efficacy and Safety of Hetrombopag as Secondary Prevention to Chemotherapy-induced Thrombocytopenia in Patients With Gynecologic MalignanciesNot yet recruitingPhase 2Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNCT06099925Written as Hetrombopag
- Study of the Food Effects of Herombopag Olamine Tablets in Healthy SubjectsNot yet recruitingPhase 1Jiangsu HengRui Medicine Co., Ltd.NCT06062680Written as Herombopag Olamine Tablets
See all 52 studies that test hetrombopag →
Given in every arm · 1 — hetrombopag is usual care beside what is tested
Codes
What other systems call hetrombopag · ClinicalTrials.gg INT000612
- MeSH (NLM) C000614661hetrombopagConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 9WGT51BDDLRAFUTROMBOPAGConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000614661 | hetrombopag | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 9WGT51BDDL | RAFUTROMBOPAG | Confirmed FDA, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.